Limitation of activities of daily living and quality of life based on COPD combined classification

Respiratory Care

Volumn 60, Issue 3, 2015, Pages 388-398

  Barusso, Marina S ^a   Gianjoppe Santos, Júlia ^a   Basso Vanelli, Renata P ^a   Regueiro, Eloisa Mg ^b   Panin, Jéssica C ^a   Di Lorenzo, Valéria A Pires ^a  

^a FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^b and the Centro Universitário Claretiano ^*  (Brazil)

Author keywords

COPD classification; Daily living activities; Dyspnea; Oxygen desaturation; Quality of life

Indexed keywords

ACTIVITY OF DAILY LIVING ASSESSMENT; AGE; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY QUESTIONNAIRE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE EXACERBATION; DYSPNEA; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HOME OXYGEN THERAPY; HUMAN; MALE; OBSERVATIONAL STUDY; OXYGEN DESATURATION; PULMONARY REHABILITATION; QUALITY OF LIFE ASSESSMENT; RISK FACTOR; SMOKING HABIT; CLASSIFICATION; DAILY LIFE ACTIVITY; FOLLOW UP; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; WALKING;

ACTIVITIES OF DAILY LIVING; AGED; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; OXYGEN CONSUMPTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES; WALKING;

EID: 84938254997     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.03202     Document Type: Article

References (38)

1. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187(4):347-365.
2. Agustí A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010;11:122.
3. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of COPD. Updated 2014. http://www.goldcopd.org. Accessed October 16, 2014.
4. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006;173(12):1390-1413.
5. Skumlien S, Hagelund T, Bjørtuft O, Ryg MS. A field test of functional status as performance of activities of daily living in COPD patients. Respir Med 2006;100(2):316-323.
6. Cutaia M, Brehm R, Cohen M. The relationship of the BODE index to oxygen saturation during daily activities in patients with chronic obstructive pulmonary disease. Lung 2011;189(4):269-277.
7. Polkey MI, Moxham J. Attacking the disease spiral in chronic obstructive pulmonary disease. Clin Med 2006;6(2):190-196.
8. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54(7):581-586.
9. Garrod R, Bestall JC, Paul EA, Wedzicha JA, Jones PW. Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL). Respir Med 2000;94(6):589-596.
10. Kinsman RA, Yaroush RA, Fernandez E, Dirks JF, Schocket M, Fukuhara J. Symptoms and experiences in chronic bronchitis and emphysema. Chest 1983;83(5):755-761.
11. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T, Izumi T. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest 1999; 116(6):1632-1637.
12. Reardon JZ, Lareau SC, ZuWallack R. Functional status and quality of life in chronic obstructive pulmonary disease. Am J Med 2006; 119(10 Suppl 1):32-37.
13. Marchiori RC, Susin CF, Dal Lago L, Felice CD, Brandaõ da Silva D, Severo MD. Diagnosis and treatment of COPD exacerbated in emergency. Revista da AMRIGS 2010;54(2):214-223.
14. Kovelis D, Segretti NO, Probst VS, Lareau SC, Brunetto AF, Pitta F. Validation of the Modified Pulmonary Functional Status and Dyspnea Questionnaire and the Medical Research Council scale for use in Brazilian patients with chronic obstructive pulmonary disease. J Bras Pneumol 2008;34(12):1008-1018.
15. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166(1):111-117.
16. Camelier A, Rosa FW, Salim C, Nascimento OA, Cardoso F, Jardim JR. Using the Saint George’s Respiratory Questionnaire to evaluate quality of life in patients with chronic obstructive pulmonary disease: validating a new version for use in Brazil. J Bras Pneumol 2006;32(2):114-122.
17. Pitta F, Probst VS, Kovelis D, Segretti NO, Mt Leoni A, Garrod R, Brunetto AF. Validation of the Portuguese version of the London Chest Activity of Daily Living Scale (LCADL) in chronic obstructive pulmonary disease patients. Rev Port Pneumol 2008;14(1):27-47.
18. Jones PW, Quirk FH, Baveystock CM. The St George’s Respiratory Questionnaire. Respir Med 1991;85(Suppl B):S25-S31; discussion 33-37.
19. Sousa TC, Jardim JR, Jones P. Validation of the Saint George’s Respiratory Questionnaire in patients with chronic obstructive pulmonary disease in Brazil. J Pneumol 2000;26(3):119-128.
20. Iwama AM, Andrade GN, Shima P, Tanni SE, Godoy I, Dourado VZ. The six-minute walk test and body weight-walk distance product in healthy Brazilian subjects. Braz J Med Biol Res 2009;42(11): 1080-1085.
21. Ries AL. Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. COPD 2005;2(1):105-110.
22. Andrianopoulos V, Franssen FM, Peeters JP, Ubachs TJ, Bukari H, Groenen M, et al. Exercise-induced oxygen desaturation in COPD patients without resting hypoxemia. Respir Physiol Neurobiol 2014; 190:40-46.
23. Dal Corso S, Duarte SR, Neder JA, Malaguti C, de Fuccio MB, de Castro Pereira CA, Nery LE. A step test to assess exercise-related oxygen desaturation in interstitial lung disease. Eur Respir J 2007; 29(2):330-336.
24. Soguel Schenkel N, Burdet L, de Muralt B, Fitting JW. Oxygen saturation during daily activities in chronic obstructive pulmonary disease. Eur Respir J 1996;9(12):2584-2589.
25. Vogiatzis I, Zakynthinos S. Factors limiting exercise tolerance in chronic lung diseases. Compr Physiol 2012;2(3):1779-1817.
26. Velloso M, Stella SG, Cendon S, Silva AC, Jardim JR. Metabolic and ventilatory parameters of four activities of daily living accomplished with arms in COPD patients. Chest 2003;123(4):1047-1053.
27. Tangri S, Woolf CR. The breathing pattern in chronic obstructive lung disease during the performance of some common daily activities. Chest 1973;63(1):126-127.
28. Decramer M, De Benedetto F, Del Ponte A, Marinari S. Systemic effects of COPD. Respir Med 2005;99(Suppl 2):S3-S10.
29. Regueiro EM, Lorenzo VA, Parizotto AP, Negrini F, Sampaio LM. Analysis of metabolic and ventilatory demand during the execution of daily life activities in individuals with chronic obstructive pulmonary disease. Rev Lat Am Enfermagem 2006;14(1):41-47.
30. Lee L, Friesen M, Lambert IR, Loudon RG. Evaluation of dyspnea during physical and speech activities in patients with pulmonary diseases. Chest 1998;113(3):625-632.
31. Velloso M, Jardim JR. Study of energy expenditure during activities of daily living using and not using body position recommended by energy conservation techniques in patients with COPD. Chest 2006; 130(1):126-132.
32. Vaes AW, Wouters EF, Franssen FM, Uszko-Lencer NH, Stakenborg KH, Westra M, et al. Task-related oxygen uptake during domestic activities of daily life in patients with COPD and healthy elderly subjects. Chest 2011;140(4):970-979.
33. Mahler DA. Mechanisms and measurement of dyspnea in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006;3(3):234-238.
34. O’Donnell DE, Banzett RB, Carrieri-Kohlman V, Casaburi R, Davenport PW, Gandevia SC, et al. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proc Am Thorac Soc 2007;4(2):145-168.
35. Rodriguez Gonzalez-Moro JM, de Lucas Ramos P, Izquierdo Alonso JL, López-Muñiz Ballesteros B, Antón Díaz E, Ribera X, Martín A. Impact of COPD severity on physical disability and daily living activities: EDIP-EPOC I and EDIP-EPOC II studies. Int J Clin Pract 2009;63(5):742-750.
36. Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med 2011;105(1):57-66.
37. Antonelli-Incalzi R, Imperiale C, Bellia V, Catalano F, Scichilone N, Pistelli R, et al. Do GOLD stages of COPD severity really correspond to differences in health status? Eur Respir J 2003;22(3):444-449.
38. Hsu KY, Lin JR, Lin MS, Chen W, Chen YJ, Yan YH. The modified Medical Research Council dyspnoea scale is a good indicator of health-related quality of life in patients with chronic obstructive pulmonary disease. Singapore Med J 2013;54(6):321-327.